Glucose Tolerance Test, 2 Hour Post-75g Oral Ingestion
The Glucose Tolerance Test (GTT) is used to establish the diagnosis of diabetes mellitus or insulin resistance in patients who have an elevated fasting glucose level. The test is useful because type I diabetes diagnosis is usually straightforward based on patient history, clinical symptoms, etc. Type II is more difficult to diagnose; however, the GTT can improve early diagnosis. The GTT is performed by a series of glucose measurements after the ingestion of orally administered glucose. In normal individuals the glucose level will rise within 30 to 60 minutes and then slowly decrease as insulin secretion is stimulated. After about two-and-one-half hours the glucose level tends to fall just below fasting, and levels usually return to normal in about three hours. In diabetic patients the levels remain higher for a longer period before slowly returning to normal. Impaired GTT can be noted in illness, trauma, stress, endocrinopathies, and certain drugs that induce hyperglycemia. For individuals who have poor absorption of oral glucose or who are unable to tolerate an oral carbohydrate load, an intravenous glucose tolerance test (IGTT) can be an alternative. With this test, insulin levels are often monitored along with the glucose measurement. A five-hour test may be useful in detecting postprandial hypoglycemia because values will continue to drop below normal during the 4- and 5-hour measurements.
- Diagnosis of diabetes mellitus
- Diagnosis of insulin resistance (impaired glucose tolerance)
- Differential diagnosis of gestational diabetes
- As an aid in diagnosis of pancreatic disease
- To help diagnose reactive hypoglycemia
- To aid in the evaluation of acromegaly
Increased in:
- Diabetes mellitus
- Impaired glucose tolerance
- Pancreatic disease
- Severe liver disease
- Hyperthyroidism
- Cushing’s syndrome
- In some drugs such as diuretics, oral contraceptives, glucocorticoids
Decreased in:
- Intestinal disease such as celiac sprue (malabsorption)
- Whipple’s disease
- Adrenal insufficiency (Addison’s disease, hypopituitarism)
- Pancreatic islet cell tumors (hyperplasia)
- Reactive hypoglycemia
3 Hour Gestational Glucose Tolerance 100g (24-28 G. Weeks)
Fasting: 65-105mg/dL (3.6-5.8 mmol/L)
1-Hour: 65-190mg/dL (3.6-10.5 mmol/L)
2-Hour: 65-165mg/dL (3.6- 9.2 mmol/L)
3-Hour: 65-145mg/dL (3.6-8.0 mmol/L)
ACOG recommendation used for this panel
2 Hour Gestational Glucose Tolerance 75g (24-28 G. Weeks)
Fasting: 65-92mg/dL (3.6-5.1 mmol/L)
1-Hour: 65-180mg/dL (3.6-10.0 mmol/L)
2-Hour: 65-153mg/dL (3.6-8.5 mmol/L)
ADA recommendation used for this panel
1 Hour Gestational Glucose Tolerance, 50g (24-28 G. Weeks)
Fasting: 65-92mg/dL (3.6-5.1 mmol/L)
1-Hour: 65-140mg/dL (3.6-7.8 mmol/L)
ADA recommendation used for this panel
3 Hour Glucose Tolerance 100g Non-Gestational
Fasting: 65-95mg/dL (3.6-5.3 mmol/L)
1-Hour: 65-180mg/dL (3.6-10.0 mmol/L)
2-Hour: 65-155mg/dL (3.6-8.6 mmol/L)
3-Hour: 65-140mg/dL (3.6-7.8 mmol/L)
ADA recommendation used for this panel
2 Hour Glucose Tolerance 75g Non-Gestational
Fasting: 65-91mg/dL (3.6-5.1 mmol/L)
1-Hour: 65-179mg/dL (3.6-9.9 mmol/L)
2-Hour: 65-152mg/dL (3.6-8.4mmol/L)
ADA recommendation used for this panel
1 Hour Glucose Tolerance, 50g Non-Gestational
Fasting plasma glucose <110 mg/dL (<6.1 mmol/L)
1-hour 70-140 mg/dL (3.9-7.8 mmol/L
ADA recommendation used for this panel
Serum (SST), Plasma Oxalate (Grey) or Plasma Heparin (Green)
- Non Pregnant: draw at fasting and 120 min after glucose administration.
- Pregnant: draw at fasting, 60, 120 and 180 min after glucose.
Doses:
- Non-Pregnant: 75 g orally
- Pregnant: 100 g orally
Stability
- Child: 1.75 g/kg
- Ambient - 4 days
- Refrigerated - 7 days
- Frozen - 28 days
- Eur J Clin Nutr. 2011 Dec 14. doi: 10.1038/ejcn.2011.203. [PMID: 22166897]
- Clin Chem Lab Med. 2003;41:1239. [PMID: 14598876]
- Diabetes Care. 2005;28:2626. [PMID: 16249530]
- Clin Chem Lab Med. 2006;44:99. [PMID: 16375594]
- Anderson SC, Cockayne S. Clinical Chemistry: Concepts and Applications. Philadelphia. W.B. Saunders Company (1993).